Skip to main content

Checkmate Pharmaceuticals, Inc.

CMPIDelisted
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001651431

Checkmate Pharmaceuticals, Inc. was delisted in 2022; its insiders filed their last Form 4 on May 31, 2022; 26 institutions reported holding it in 13F filings for Q1 2022, worth $54.8M in total; no superinvestor held it.

Superinvestors holding CMPI, Q1 2022

See all superinvestors

No superinvestor reported holding CMPI in Q1 2022.